Immutep Ltd ADR share price logo

Immutep Ltd ADR

NASDAQ: IMMP

Small Cap

$0.44

-0.01

(-3.06%)

as on

Immutep Ltd ADR Stock Performance

as on May 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.43
    $0.46
    downward going graph

    2.27%

    Downside

    4.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.29
    $3.53
    downward going graph

    33.45%

    Downside

    702.25%

    Upside

    downward going graph

Immutep Ltd ADR share price movements today

Previous Close
$0.45
Open
$0.45
Volume
1.5M
Day's Low - High
$0.43 - $0.46
52 Week Low - High
$0.29 - $3.53

Immutep Ltd ADR Historical Returns

1 Month Return
-13.5 %
3 Month Return
-83.8 %
1 Year Return
-77.2 %
3 Year Return
-78.7 %
5 Year Return
-90.59 %

Immutep Ltd ADR Stock Fundamentals & Key Indicators

Check Immutep Ltd ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$71.6M

EPS (TTM)

-0.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-82.4M

Revenue (TTM)

7.9M

Profit Margin

0.00%

Return On Equity TTM

-61.85%

Immutep Ltd ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immutep Ltd ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Immutep Ltd ADR image
Immutep Ltd ADR
BUY$71.6M-90.59%NA0.00%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.7B110.73%74.5512.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.3B110.28%25.7735.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$67.0B28.12%15.629.65%0.5599999999999999%

Stock Returns calculator for Immutep Ltd ADR Stock including INR - Dollar returns

The Immutep Ltd ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immutep Ltd ADR investment value today

Current value as on today

₹24,795

Returns

-₹75,205

(-75.2%)

Returns from Immutep Ltd ADR Stock

-₹77,889 (-77.89%)

Dollar Impact

₹2,685 (+2.68%)

Analyst Recommendation on Immutep Ltd ADR Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Immutep Ltd ADR. Average target price of $1

Immutep Ltd ADR Share Price Target

Get share price movements and forecasts by analysts on Immutep Ltd ADR.

What analysts predicted

56%UPSIDE

Target Price

$1

Current Price

$0.44

Analyzed by

9 Analysts

Target

$1.00

Immutep Ltd ADR target price $1, a slight upside of 56% compared to current price of $0.44. According to 9 analysts rating.

Indian Investors' Interest in Immutep Ltd ADR Stock

Search interest for Immutep Ltd ADR Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Immutep Ltd ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Sep 2023
Dec 2023
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
1
1
2
1
1
3
1
6
Gross Profit
0
0
1
-19
-19
-22
-34
-40
Operating Income
-23
-21
-43
-44
-44
-51
-74
-46
EBITDA
-20
-19
-22
-22
-22
-26
-36
-44
Interest Expense
0
0
0
0
0
-
-
0
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-20
-19
-21
-21
-21
-22
-39
-44
Income Tax Expense
0
0
0
21
21
-
-
-
Net Income
-13
-19
-21
-21
-21
-22
-39
-44
Net Profit Margin
-1223.54%
-1058.85%
-1005.72%
-1241.29%
-1241.29%
-710.92%
-2059.84%
-744.36%

Immutep Ltd ADR Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
3
1
0
5
2
0
2
2
5
Gross Profit
-5
1
-5
-11
-10
-10
-1
0
-25
-56
Operating Income
-61
-9
-11
-20
-16
-31
-33
-77
-88
-126
EBITDA
-61
-8
-10
-16
-11
-17
-31
-39
-44
-62
Interest Expense
0
-
-
-
0
0
0
0
0
-
Depreciation
-
1
1
1
2
2
2
-
-
-
Income Before Tax
-63
-10
-12
-18
-13
-29
-32
-39
-42
-61
Income Tax Expense
-1
0
0
-2
0
0
0
0
0
-
Net Income
-45
-7
-9
-11
-9
-22
-22
-26
-28
-61
Net Profit Margin
-35426.72%
-221.89%
-484.55%
-11640.01%
-179.90%
-774.12%
-18906.51%
-1138.04%
-1111.87%
-1218.02%

Immutep Ltd ADR Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Mar 2026
Net Income
-21
-
-21
-21
-22
-
-39
-44
-
Operating Cash Flow
-17
-
-16
-7
-28
-
-33
-28
-
Investing Cash Flow
0
-
-
-20
-30
-
24
34
-
Financing Cash Flow
0
0
95
95
0
0
0
0
0
Change in Cash
-6
-8
58
66
-46
-
-73
6
-

Immutep Ltd ADR Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-9
-12
-18
-13
-29
-32
-39
-42
-61
Operating Cash Flow
-8
-7
-15
-10
-17
-30
-35
-34
-62
Investing Cash Flow
0
0
0
0
0
0
0
-21
-38
Financing Cash Flow
0
18
8
20
52
50
76
95
0
Change in Cash
-8
11
-6
9
34
19
43
38
-94

Global Institutional Holdings in Immutep Ltd ADR

Funds
Holdings
Morgan Stanley - Brokerage Accounts
0.01%
Two Sigma Investments LLC
0.08%
Virtu Financial LLC
0.02%
BlackRock Inc
0.56%
Geode Capital Management, LLC
0.01%
See all

Immutep Ltd ADR News & Key Events

    Insights on Immutep Ltd ADR

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 1.89M → 6.02M (in $), with an average increase of 68.5% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 5.2% return, outperforming this stock by 82.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Immutep Limited American Depositary Shares has experienced a drawdown of -78.7%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 66.2%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 7 quarters, -19.27M → -44.85M (in $), with an average decrease of 17.5% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 3 months, IMMP stock has moved down by -83.8%

    About Immutep Ltd ADR

    Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.
    OrganisationImmutep Ltd ADR
    HeadquartersAustralia Square, Sydney, NSW, Australia, 2000
    IndustryBiotechnology
    CEOMr. Marc Voigt
    E-voting on sharesClick here to vote

    Key Management of Immutep Ltd ADR

    Name

    Title

    Mr. Marc Voigt

    CEO, MD, CFO, Chief Business Officer & Executive Director

    Ms. Deanne Miller LLB

    COO, General Counsel & Joint Company Secretary

    Dr. Frederic Triebel M.D., Ph.D.

    Chief Scientific Officer & Executive Director

    Mr. Christian Mueller BBA, MSc.

    Chief Development Officer

    Dr. Stephan Winckels M.D., Ph.D.

    Chief Medical Officer

    Ms. Indira Naidu

    Joint Company Secretary

    FAQs

    What is Immutep Ltd ADR share price today?

    Immutep Ltd ADR share price today is $0.44 as on at the close of the market. Immutep Ltd ADR share today touched a day high of $0.46 and a low of $0.43.

    What is the 52 week high and 52 week low for Immutep Ltd ADR share?

    Immutep Ltd ADR share touched a 52 week high of $3.53 on and a 52 week low of $0.29 on . Immutep Ltd ADR stock price today i.e. is closed at $0.44,which is 87.54% down from its 52 week high and 50.27% up from its 52 week low.

    What is Immutep Ltd ADR's market capitalisation today?

    Immutep Ltd ADR market capitalisation is $0.00T as on .

    How to invest in Immutep Ltd ADR Stock (IMMP) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immutep Ltd ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immutep Ltd ADR Shares that will get you 3.4091 shares as per Immutep Ltd ADR share price of $0.44 per share as on May 28, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Immutep Ltd ADR Stock (IMMP) from India?

    Indian investors can start investing in Immutep Ltd ADR (IMMP) shares with as little as ₹95.69 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹956.90 in Immutep Ltd ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Immutep Ltd ADR share’s latest price of $0.44 as on May 28, 2026 at 1:29 am IST, you will get 22.7273 shares of Immutep Ltd ADR. Learn more about fractional shares .

    What are the returns that Immutep Ltd ADR has given to Indian investors in the last 5 years?

    Immutep Ltd ADR stock has given -90.59% share price returns and 30.98% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?